Monthly tralokinumab is an effective dosing regimen for patients with atopic dermatitis who have achieved stable disease control.

RelabotulinumtoxinA resulted in statistically significant improvements in moderate to severe lateral canthal lines and was well-tolerated.

Women were a younger mean age at melanoma diagnosis when compared with men across all anatomic sites and most Breslow thickness categories.

The ACS has released cancer statistics for 2025 suggesting that more than 2 million new cases of cancer will be diagnosed in the US this year.

A scientific statement regarding nursing wellness in cardiovascular and stroke care has been published by the American Heart Association.

Adults reporting medical-only or medical-nonmedical cannabis use may have higher prevalence of CUD than those reporting nonmedical only.

Self-reported manifestations of topical steroid withdrawal in atopic dermatitis include erythema, desquamation, dryness, and oozing.

The majority of patients with postacute sequelae of COVID-19/post-COVID-19 syndrome do not recover in the second year of their illness.

The US FDA has warned Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ingredients.